Training materials

Copyright © 2025 LexisNexis

Our training materials consist of template PowerPoint slides and are designed to be used as the starting point for a range of presentations covering Life Sciences issues on which a lawyer might commonly be asked to provide training. The materials are intended to be a time-saving tool for in-house counsel presenting to their businesses about key legal compliance issues, and to private practice lawyers giving internal training or external client

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

Existing user? Sign-in TAKE A FREE TRIAL
Powered by Lexis+®
Latest Life Sciences News

MHRA launches consultation to evaluate the Medicines and Medical Devices Act 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation seeking stakeholder feedback on the operation and impact of medicines and medical devices legislation. The review, mandated under Part 6, Regulation 48 of the Medicines and Medical Devices Act 2021, examines four key regulations: the Human Medicines Regulations 2012, Medical Devices Regulations 2002, Medicines for Human Use (Clinical Trials) Regulations 2004, and Medicines and Medical Devices (Fees) Regulations. The consultation, running until 19 September 2025, aims to assess whether the legislation effectively protects public health without imposing unnecessary regulatory burdens. Findings will inform a report to be published by the Secretary of State for Health and Social Care.

European Parliament publishes study on AI and civil liability

The European Parliament’s Policy Department for Justice, Civil Liberties and Institutional Affairs has published a study examining the EU’s regulatory approach to civil liability for artificial intelligence (AI) systems. The study, commissioned at the request of the Committee on Legal Affairs, recommends implementing a strict liability regime for high-risk AI systems. It advocates for a single responsible operator model to prevent regulatory fragmentation across EU Member States and emphasises the importance of legal certainty, efficiency and harmonisation in the regulatory framework.

MHRA  launches world-first framework for decentralised manufacture of personalised medicines

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that the application date for groundbreaking new UK legislation has arrived from 23 July 2025. The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025, SI 87/2025 will provide the world's first regulatory framework that allows breakthrough personalised medicines such as cancer and immunotherapy (ie CAR-T) treatments to be prepared in small or individual batches. It aims to transform the manufacture of innovative medicines at the point of patient care.

EFRAG launches portal analysing 1st ESRS sustainability statements

The European Financial Reporting Advisory Group (EFRAG) has launched its 'EFRAG 2025 State of Play' portal, providing analysis of the first 656 European Sustainability Reporting Standards (ESRS) statements issued under the Corporate Sustainability Reporting Directive (CSRD). The portal includes a statistics dashboard and report repository showing only 10% of companies identified all ESRS standards as material, while 55% disclosed climate transition plans. The analysis will inform EFRAG's work on ESRS simplification following the European Commission's March 2025 mandate.

View Life Sciences by content type :  
News
Practice notes
Precedents
Q&As

Popular documents

What is the difference between an appeal and a review?

What is the difference between an appeal and a review?What is an appeal?An appeal in insolvency proceedings is no different to an appeal in normal litigation. An appeal will be allowed only if the appeal court is satisfied that the decision of the lower court was 'wrong' or 'unjust because of a

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Strike out—making an application to strike out a statement of case

Strike out—making an application to strike out a statement of caseA strike out order can be made either following an application by the parties or on the court's own initiative. This Practice Note deals with the scenario of the order being made following a party's application.Making an application

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of
What is the difference between an appeal and a review?

What is the difference between an appeal and a review?

What is the difference between an appeal and a review?What is an appeal?An appeal in insolvency proceedings is no different to an appeal in normal litigation. An appeal will be allowed only if the appeal court is satisfied that the decision of the lower court was 'wrong' or 'unjust because of a

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Strike out—making an application to strike out a statement of case

Strike out—making an application to strike out a statement of case

Strike out—making an application to strike out a statement of caseA strike out order can be made either following an application by the parties or on the court's own initiative. This Practice Note deals with the scenario of the order being made following a party's application.Making an application

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of